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The cytochrome bd-I respiratory 
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Nitric oxide (NO) is a toxic free radical produced by neutrophils and macrophages in response to 
infection. Uropathogenic Escherichia coli (UPEC) induces a variety of defence mechanisms in response 
to NO, including direct NO detoxification (Hmp, NorVW, NrfA), iron-sulphur cluster repair (YtfE), and 
the expression of the NO-tolerant cytochrome bd-I respiratory oxidase (CydAB). The current study 
quantifies the relative contribution of these systems to UPEC growth and survival during infection. 
Loss of the flavohemoglobin Hmp and cytochrome bd-I elicit the greatest sensitivity to NO-mediated 
growth inhibition, whereas all but the periplasmic nitrite reductase NrfA provide protection against 
neutrophil killing and promote survival within activated macrophages. Intriguingly, the cytochrome 
bd-I respiratory oxidase was the only system that augmented UPEC survival in a mouse model after 
2 days, suggesting that maintaining aerobic respiration under conditions of nitrosative stress is a 
key factor for host colonisation. These findings suggest that while UPEC have acquired a host of 
specialized mechanisms to evade nitrosative stresses, the cytochrome bd-I respiratory oxidase is the 
main contributor to NO tolerance and host colonisation under microaerobic conditions. This respiratory 
complex is therefore of major importance for the accumulation of high bacterial loads during infection 
of the urinary tract.
Urinary tract infections (UTIs) are among the most common infectious diseases of humans and are the most 
common nosocomial infection in the developed world. They cause significant morbidity and mortality, with 
~150 million cases globally per year1. Uropathogenic Escherichia coli (UPEC) cause the majority (~80%) of UTI 
in humans, including cystitis (bladder infection), pyelonephritis (kidney infection) and, in severe cases, urosep-
sis1. UPEC infection of the bladder results in the rapid influx of neutrophils and macrophages2, the activation 
of resident tissue macrophages and dendritic cells, and the release of proinflammatory cytokines3. Additionally, 
during infection UPEC encounters nitric oxide (NO), a membrane-soluble free radical that mediates its bac-
tericidal effects via reaction with iron-sulphur clusters4, haem proteins5 and protein thiol groups6. A major 
source of NO is from host NO synthases, especially the inducible NO synthase (iNOS), which is activated in 
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macrophages, for example, by bacterial lipopolysaccharide (LPS)7 and certain inflammatory cytokines, par-
ticularly interferon-gamma (IFN-γ )8. Other sources of NO include bacterial reduction of dietary nitrate, and 
the reactions of salivary nitrite with stomach acid to generate NO. There is no evidence for NOS activity in 
E. coli, although several bacteria including Staphylococcus aureus9, Bacillus subtilis10, Helicobacter pylori11 and 
Streptomyces species12 possess genes encoding NOS-like proteins.
Gram-negative bacteria can respond to NO-stress in a variety of ways, including detoxification via the flavo-
hemoglobin Hmp13,14, the flavorubredoxin NorVW15, the nitrite reductase NrfA16, and the recently characterised 
NO reductase system Hcp/Hcr17. In addition, E. coli also utilises the diiron protein YtfE to repair iron-sulphur 
clusters damaged by nitrosative stress18, and possesses the NO-inducible cytochrome bd-I respiratory oxidase that 
confers resistance to NO19,20. Finally, efflux of glutathione and cysteine by the ABC transporter CydDC has also 
been shown to provide tolerance to nitric oxide21 (presumably via reaction of NO with these thiols), although the 
majority of the NO-tolerance effects result from the requirement of CydDC for the assembly of the NO-tolerant 
cytochrome bd-I terminal oxidase. The cytochrome bd-I complex, encoded by the cydABX operon, is expressed 
maximally in microaerobic environments under the dual control of the transcription factors ArcA and FNR22,23, 
and is up-regulated in response to NO20. Rather than catalyzing the decomposition of NO, cytochrome bd-I is 
an NO-tolerant terminal oxidase of the respiratory chain that permits aerobic respiration in the presence of NO 
and low oxygen19. Crucially, oxygen tension heavily influences the expression and efficacy of the above systems 
to provide protection against nitrosative stress16, and the relative importance of the mechanisms used to respond 
to NO stress for growth and survival of UPEC during microaerobic growth in the bladder remain to be fully 
elucidated. A recent transcriptomic study demonstrates that the cytochrome bd-I complex is highly-expressed in 
UPEC isolated from patients with UTI24, confirming that microaerobic conditions are encountered during infec-
tion, so the contribution of this system to NO tolerance is of particular interest to UPEC survival. In this study, we 
mutated the hmp, cydAB, norVW, nrfA and ytfE genes from a multidrug-resistant UPEC strain (EC958)25 from 
the recently emerged and globally disseminated ST131 lineage26,27. A hcp/hcr mutant was not constructed as this 
system is expressed only under anaerobic conditions, whereas the current study utilised microaerobic conditions 
to simulate conditions in the bladder. Mutant strains were assessed for growth inhibition in response to NO, for 
survival following neutrophil exposure, and for survival within activated macrophages. In addition, a mouse UTI 
model was used to assess the relative ability of the mutant strains to colonise the bladder. Our data indicate that 
loss of the cytochrome bd-I complex has the greatest impact upon the ability of UPEC to resist the challenges 
encountered during infection of the urinary tract.
Results
E. coli K-12 and clinical isolates exhibit similar sensitivity to an NO-releaser. To assess the sensitiv-
ity of UPEC to nitrosative stress, well diffusion assays were conducted with the NO releaser S-nitrosoglutathione 
(GSNO) using well-characterised UPEC strains associated with symptomatic (CFT073 and EC958) or asympto-
matic (83972) infection, and the reference K-12 commensal strain MG1655. To simulate conditions during blad-
der infection, this experiment was conducted under a microaerobic atmosphere as microaerobically-expressed 
loci such as cydAB have previously been shown to be up-regulated during bladder infection24. The three UPEC 
strains exhibited a similar level of sensitivity to nitric oxide (EC958 = 12.7 ± 0.2 mm; CFT073 = 12.2 ± 0.2 mm; 
83972 = 11.3 ± 0.2 mm) comparable to the sensitivity of MG1655 (10.3 ± 0.2 mm). Thus, toxicity to nitric oxide 
is conserved among the UPEC strains tested.
Cytochrome bd-I and Hmp facilitate growth of EC958 in the presence of NO. Gram-negative 
bacteria can respond to NO-stress in a variety of ways (Fig. 1A). To investigate which systems are important 
for tolerance to nitrosative stress in UPEC, genes encoding cytochrome bd-I (cydAB), Hmp, NorVW, NrfA and 
YtfE were deleted in EC958. Growth of wild type EC958, and cydAB, hmp, nrfA, norVW and ytfE mutants was 
monitored following addition of the NO-releaser NOC-12 (Fig. 1B–G). NOC-12 was preferred over GSNO in 
these experiments due to its NO-specific properties and amenability for use in small volume liquid growth exper-
iments. Based on the NOC-12 growth data, mutation of cydAB and hmp conferred the greatest sensitivity to NO 
in the presence of 0.2 mM and 0.5 mM NOC-12 (Fig. 1H). This suggests that respiratory insensitivity to NO 
via cytochrome bd-I and NO-detoxification via the flavohemoglobin Hmp provide the greatest contribution to 
growth under these conditions. These growth defects were confirmed to result from loss of cydAB and hmp via 
complementation of the NO-sensitive phenotypes with plasmids containing the hmp and cydABX genes, respec-
tively (Fig. 2). Cytochrome bd-I assembly was also monitored using whole cell CO difference spectroscopy. Using 
this approach, restoration of cytochrome bd-I assembly in the complemented cydAB mutant was verified based 
on its spectral features (Figure S1, Supplementary Information).
NO resistance mechanisms of EC958 enhance survival in the presence of neutrophils and promote 
survival in macrophages. Bacterial infection has previously been shown to induce nitric oxide synthase 
activity in human neutrophils28. The EC958 wild type, cydAB, hmp, norVW, nrfA and ytfE strains described above 
were tested for their ability to survive exposure to primary human neutrophils. In these experiments cydAB, 
hmp, norVW and ytfE mutants displayed increased sensitivity to neutrophil killing compared to wild type EC958, 
whereas loss of nrfA did not affect survival (Fig. 3). Similarly, infection of murine macrophages (lipopolysaccha-
ride (LPS) and IFN-γ -activated to produce nitric oxide29) demonstrated that mutation of cydAB, hmp, norVW 
and ytfE led to a significant reduction in bacterial loads at 2 h post-infection, whereas loss of nrfA had no dis-
cernible effect (Fig. 4A). There was no decrease in survival of the cydAB and hmp mutant strains (compared to 
wild type) in the presence of non-primed macrophages (Fig. 4B), suggesting that NO is a major contributor to 
the killing of these mutant strains by macrophages. Furthermore, to confirm that primed macrophages were 
indeed producing NO, nitrite assays were undertaken (nitrite is a by-product of NO generation): nitrite could 
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Figure 1. Loss of cydAB and hmp impairs growth in the presence of NO. (A) The NO-resistance mechanisms 
of E. coli: i) An NO-tolerant respiratory oxidase19 is induced (known as CydAB or cytochrome bd-I), which 
facilitates aerobic respiration under microaerobic conditions; ii) NO is converted to nitrate or nitrous oxide 
by the Flavohemoglobin Hmp under aerobic55 or anaerobic56 conditions, respectively; iii) NO is reduced 
by the periplasmic cytochrome c Nitrite Reductase NrfA57; iv) NO is converted to nitrous oxide via the 
Flavorubredoxin/Flavorubredoxin Reductase system NorVW15; v) The diiron protein YtfE repairs iron-sulphur 
clusters damaged by nitrosative stress18. (B–G) Cultures were grown under microaerobic conditions, and 
growth rates were measured following the addition of NOC-12 (0.2 mM and 0.5 mM). Error bars represent 
SD values. (H) Data from panels B-G are plotted as % growth rate compared to identical cultures grown 
in the absence of NOC-12. Error bars represent SEM. All data points are mean values calculated from five 
repeats. Asterisks indicate that rates measured in the presence of NOC-12 are significantly different from those 
measured in the absence of NOC-12 (Student’s t-test, P < 0.0001).
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not be detected in non-primed cells whereas addition of both LPS and IFN-γ resulted in a nitrite concentration 
of 25 ± 0.8 μ M. It is worth noting that this is a measure of accumulated nitrite pre-infection following 16 h of 
exposure to LPS/IFN-γ , and is not a measure of in vivo NO concentrations.
Cytochrome bd-I contributes to EC958 survival in the mouse bladder. To assess the contribution 
of defence mechanisms against NO to EC958 virulence, we tested the ability of the EC958 wild type, cydAB, 
hmp, norVW and ytfE mutants to survive in the mouse urinary tract using a competitive infection assay. We 
employed an EC958lac strain as the wild type to enable differentiation of both strains on MacConkey lactose 
medium; EC958lac had an identical growth rate in LB broth to wild type EC95830, produced type 1 fimbriae 
in similar levels and colonised the mouse bladder in equivalent numbers in a mixed competitive infection31. 
Female C57BL/6 mice were infected with 1:1 ratio of EC958lac and each mutant, respectively, and colonisation 
was assessed at 2-days post-infection. In these experiments, only the cydAB mutant displayed an attenuated col-
onisation phenotype (Fig. 5). EC958cydAB was significantly outcompeted by EC958lac in the bladder of infected 
Figure 2. Complementation of NO-sensitive growth defects of cydAB and hmp mutants. E. coli EC958 
knockout mutants of cydAB and hmp (EC958) were transformed with pSU2718 expression vectors (Table S2)  
containing the hmp and cydABX loci. Cultures (200 μ l) were grown in M9 medium supplemented with 
casamino acids (0.1%) and glucose (4 g/L) in 96 well plates at 100 rpm in a Spectrostar Nano microplate 
reader (BMG Labtech). Growth rates were measured following the addition of NOC-12 (0 and 0.1 mM). The 
complemented hmp strain (hmp+ ) was grown in the presence of 1 mM IPTG, whereas the complemented 
cydAB strain (cydAB+ ) relied upon the basal expression of the lac promoter for expression of low levels of the 
cydABX operon (induction of this plasmid with IPTG was toxic to the cells). Panel A depicts the growth rates 
following NOC-12 additions, and panels B–F show the raw growth data used to calculate the growth rates 
in panel A. Mean data points and P-values are calculated from at least four independent replicates. Asterisks 
indicate that rates measured in the presence of NOC-12 are significantly different from those measured in the 
absence of NOC-12 (Student’s t-test, P < 0.05).
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mice (P = 0.0156, Wilcoxon matched pairs), whereas no significant competitive difference was observed in bacte-
rial counts from the urine and kidneys of these mice (Figure S2, Supplementary Information).
Discussion
It is well-known that UPEC encounter NO during infection28,32,33, so it was of interest to ascertain whether clinical 
isolates are more resistant to nitrosative stress compared to a well-characterised K-12 strain. The data presented 
herein clearly show that a range of UPEC isolates do not exhibit elevated resistance to the NO-releaser GSNO, 
which suggests that the molecular mechanisms used by UPEC to respond to nitrosative stress may be conserved. 
Figure 3. Loss of cydAB, hmp, norVW, and ytfE enhances killing by primary human neutrophils. Mixed 
infection data are plotted as a ratio of mutant:WT colonies. The horizontal bars represent mean values. These 
data are representative of three experiments using primary human neutrophils from different blood donors. 
Asterisks indicate mutant CFU data that are significantly different from WT (Student’s t-test, P < 0.05).
Figure 4. Loss of cydAB, hmp, norVW, and ytfE diminishes survival within primed macrophages.  
(A) Survival data using primed macrophages after 2 h are expressed as a % of intracellular bacteria at 20 min 
post-infection. (B) Control data with unprimed macrophages (experiments performed as in panel A) showing 
that loss of cydAB or hmp does not diminish survival. Data are representative of 3 independent infections, 
and error bars represent SEM. Asterisks indicate data that are significantly different from WT (Student’s t-test, 
P < 0.05).
www.nature.com/scientificreports/
6Scientific RepoRts | 6:35285 | DOI: 10.1038/srep35285
To our knowledge, all complete genome sequenced UPEC strains contain the core set of NO resistance genes 
that are also found in K-12 strains (i.e., cydAB, hmp, nrfA, norVW, ytfE). An extensive literature exists on the 
NO detoxification mechanisms of E. coli and is dominated by articles on the flavohemoglobin Hmp, reflecting 
the detoxification of NO to nitrate as an important process during infection. Indeed, the UPEC strain J96 has 
previously been shown to out-compete an isogenic hmp mutant in bladder and kidney colonisation in the mouse 
UTI model14, and pharmacological modulation of Hmp activity has recently been shown to elevate NO sensitiv-
ity in multidrug-resistant UPEC strains34. It is therefore reasonable to assume that Hmp provides considerable 
protection against nitrosative stress in vivo. However, the relative importance of other NO-tolerance mechanisms, 
such as iron-sulphur cluster repair or expression of an NO-tolerant respiratory oxidase, have never been assessed 
alongside Hmp for their contribution to in vivo survival. The current work provides novel insights into the relative 
importance of a range of mechanisms involved in NO-tolerance of UPEC in the context of the globally dominant 
multidrug-resistant ST131 clone.
The growth of knockout strains in the presence of the NO-releaser NOC-12 (Figs 1 and 2) suggests that Hmp 
and cytochrome bd-I enhance the growth of UPEC under conditions of nitrosative stress and low oxygen, a 
similar environment to the bladder during UPEC infection24,35. These data display the growth rates following the 
addition of NOC-12, where diminished growth is likely to reflect a combination of bacteriostatic and bactericidal 
effects. Neutrophil killing assays (Fig. 3) indicate that all the systems under study, with the exception of NrfA, 
contribute to resistance against the nitrosative and oxidative burst produced by neutrophils. Given that loss of 
nrfA alone elicits marginal sensitivity to NO in Salmonella16 and that NrfA is only expressed under anaerobic 
conditions in the presence of nitrite/nitrate36, the behaviour of the nrfA mutant under microaerobic conditions 
used in the current study is unsurprising. In contrast, ytfE is up-regulated by nitrosative stress20,37 and has been 
shown to repair iron-sulphur clusters damaged by nitrosative and oxidative stresses18; thus our data are consistent 
with a role for this diiron protein in resistance against neutrophil killing. The norVW, hmp and cydAB genes all 
contributed to resistance against neutrophil killing, consistent with their previously characterised roles in nitric 
oxide tolerance.
Internalisation of the mutant strains by primed macrophages (Fig. 4A) reveals a similar pattern of survival 
to the neutrophil killing assays, mirroring the same hierarchical contribution towards survival. In support of 
a model in which nitrosative stress is likely responsible for diminished bacterial loads, bacterial survival was 
dramatically enhanced for the cydAB and hmp strains in the absence of LPS/IFN-γ stimulation (Fig. 4B), sug-
gesting that iNOS activity contributes significantly to the killing of these mutants. The current data are consistent 
with the previous observation that Hmp enhances survival following internalisation by human macrophages38, 
and builds upon this work by adding cytochrome bd-I, NorVW, and YtfE to the list of systems that can provide 
similar protection. Together, the neutrophil and macrophage data suggest that cytochrome bd-I may offer the 
greatest resistance to sustained nitrosative stress, a conclusion that is supported by the mouse infection data 
(Fig. 5), where only the cydAB mutant was shown to exhibit diminished colonisation of the bladder. The absence 
of a phenotype for the hmp strain in the current mouse infection studies (Fig. 5) is a little surprising, as the hmp 
gene has previously been shown to confer a modest fitness advantage during colonisation of the urinary tract of 
C3H/HeN mice by a pyelonephritis-causing J96 E. coli strain (24 h post-infection)14. The absence of impaired 
bladder colonisation for the hmp strain in the current study may reflect differences in stress tolerance between the 
J96 strain previously used14,38,39 and the EC958 multidrug-resistant strain used herein25. In addition, differences in 
the mouse strains used (C3H/HeN in previous work14 and C57BL/6 mice in the current study) and timepoints for 
bacterial quantitation (24 h and 48 h post-infection for previous14 and current studies, respectively) may also be a 
Figure 5. Deletion of cydAB impairs survival in a mouse UTI model. A minimum of eight C57BL/6 mice 
were transurethrally inoculated with ~5 × 108 CFU of each strain. After 48 h, bladder homogenate samples were 
plated on MacConkey agar in triplicate for determination of bacterial loads. After 2 days, homogenated bladder 
samples were processed for bacterial loads by viable CFU counts performed in triplicate. Data are Log of the 
fitness index, which is defined as: Fitness index = (ratio of mutant:wild type after 2 days)/(initial mutant:wild 
type ratio). A minimum of 8 mice were included in each strain group. Equality of group medians was tested 
using the Wilcoxon matched pairs signed rank test.
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contributory factor. Indeed, the infections had “generally cleared” by 48 h post-infection in the previous study14, 
potentially reflecting a more aggressive host response and/or a less resilient bacterial strain. If the bacterial strain 
is subjected to greater levels of nitrosative stress then loss of hmp is likely to have a more profound impact upon 
survival, which could explain differences in behaviour of hmp strains in the two studies. Nevertheless, the current 
data demonstrate that deletion of cydAB has a significant effect on bladder colonisation.
The recent observation that host-derived NO promotes UPEC uptake into bladder cells40 highlights the impor-
tance for NO tolerance as an important trait for UPEC during bladder colonisation, and the current data suggest 
that cytochrome bd-I facilitates this process. The transcription of the cydAB genes is also elevated in UPEC isolated 
from patients with UTI24, with mRNA transcript levels higher than those for hmp. Hence, cytochrome bd-I is likely 
to play a significant role as a dominant terminal electron acceptor of UPEC during colonisation of the urinary tract, 
enabling aerobic respiration to occur in the presence of NO levels that can inhibit other respiratory oxidases19. 
Clearly, the NO-tolerance mechanisms analysed in the current study may work in tandem to provide a concerted 
response to nitrosative stress over a range of environmental conditions. However, the current work suggests that the 
cytochrome bd-I terminal oxidase provides the greatest contribution to NO tolerance during growth in the bladder.
NO is also known to elevate biofilm dispersal in some Gram-negatives, and this process has been well-characterised 
in Pseudomonas aeruginosa41 and demonstrated more recently in Salmonella enterica and E. coli42. The ability to 
disperse biofilms and cell aggregates has clear clinical benefits, and recent combination approaches using NO and 
ciprofloxacin have proved an effective strategy to clear P. aeruginosa and E. coli O157 infections43. The current 
study provides insights into the relative importance of bacterial mechanisms of NO tolerance that are essential for 
the development of NO as a future antimicrobial therapy.
Methods
Ethical approval. This study was carried out in strict accordance with the recommendations in the Animal 
Care and Protection Act (Queensland, 2002) and the Australian Code of Practice for the Care and Use of Animals 
for Scientific Purposes (7th edition, 2004). Approval for mouse infection studies was obtained from the University 
of Queensland Animal Ethics Committee (SCMB/471/09/NHMRC (NF)). Approval for the collection of human 
blood was obtained from the University of Queensland Medical Research Ethics Committee (2008001123). All 
individuals provided written informed consent. All experimental protocols involving humans were carried out in 
accordance with the relevant guidelines and regulations.
Bacterial strains and growth conditions. E. coli EC958 is a fluoroquinolone-resistant ST131 strain 
originally isolated from the urine of a patient with UTI in the United Kingdom in 200525,44, and EC958lac is a 
previously described tagged derivative strain used to enable differential selection on MacConkey lactose agar30. 
CFT073 is a blood culture isolate from a patient with pyelonephritis (CFT073)45, 83972 is a urine isolate from an 
individual with asymptomatic bacteruria46, and MG1655 is a K-12 commensal strain47. E. coli strains were rou-
tinely cultured at 37 °C on solid or in liquid Luria-Bertani (LB) media supplemented with appropriate antibiotics 
as required (20 μ g/ml gentamycin, 30 μ g/ml chloramphenicol).
Construction of mutant strains and plasmids. Inactivation of the cydAB, hmp, norVW, nrfA, and ytfE 
genes in EC958 was performed as previously described25. The chloramphenicol resistance cassette was amplified 
from plasmid pKD325 using primers containing 50 nucleotide flanking regions complementary to the beginning 
and end of the target loci. The knock-out PCR product was introduced by electroporation into EC958 harbouring 
a gentamycin-resistant plasmid carrying the λ-Red recombinase. Allelic exchange inactivation of the target genes 
was performed as previously described48 and the constructed mutations were confirmed by sequencing of the 
mutated sites. All primers, strains and plasmids are listed in Tables S1–S3 (Supplementary Information).
Assessment of NO sensitivity. NO sensitivity was assessed on solid medium using a well diffusion assay 
with the NO-releaser GSNO. GSNO was prepared as previously described49 and quantified using the extinc-
tion coefficient ε 545 = 15.9 M−1cm−1 50. Strains were grown aerobically at 37 °C in M9 minimal medium (16 g/l 
Na2HPO4.2H2O, 3 g/l KH2PO4, 0.5 g/l NaCl, 1 g/l NH4Cl, 0.24 g/l MgSO4, 0.01 g/l CaCl2, and 4 g/l glucose) sup-
plemented with 0.1% casaminoacids, from a 1% inoculum of an overnight aerobic culture in LB media. When 
mid-log phase was reached, cells were plated in M9 minimal agar medium using the pour plate technique. Six 6 
mm diameter-wells were cut in the agar gel and 80 μ l of a 105 mM GSNO solution was added to each. Plates were 
incubated at 37 °C in microaerobic (2% oxygen) conditions in a Ruskinn InvivO2 hypoxia workstation. Average 
zones of inhibition (± SEM) were calculated from six repeats.
NO-sensitivity was assessed in liquid medium using growth curves in the presence of the slow NO-releaser 
NOC-12 (t1/2 = 100 min at 37 °C, pH 7.4) as previously described19. Briefly, cultures (200 μ L) were grown in 
96-well plates (37 °C, 160 rpm) in M9 medium supplemented with casamino acids (0.1%) and glucose (2 g/L). 
NOC-12 was suspended in 50 mM sodium phosphate pH 8.0 immediately before use and added to the culture 
when A600 reached 0.004. Growth rates were calculated from subsequent readings over the next 1.5 h.
Neutrophil killing assay. Cultures of EC958 and each of the five knockout strains (Table S3, Supplementary 
Information) were grown overnight in LB under conditions of low aeration, and primary neutrophils were freshly 
prepared from human peripheral blood the following day by discontinuous density sedimentation as previ-
ously described51. Competitive infections were performed with wild type EC958 and each of the five knockout 
strains. In each case, bacterial strains were mixed at a ratio of 1:1 and used at a final multiplicity of infection 
(MOI) of 10:1 (bacteria:neutrophil). Data are representative of three independent infections and the error bars 
represent SEM of the replicates in a single experiment performed with neutrophils. Survival was assessed at 
30 min post-infection via plating with and without chloramphenicol to enumerate total CFU and mutant CFU, 
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respectively. The significance of differences between the wild type strain and the mutant strains were assessed 
using the Student’s t-test.
Intracellular macrophage survival assay. Single infection of pre-primed RAW264.7 cells was per-
formed essentially as previously described52 at a multiplicity of infection (MOI) of 10 bacteria:1 macrophage. 
Cells were primed with 0.5 ng/ml of IFN-γ and 10 ng/ml LPS for 16 h prior to infection. After a 10 min infection 
period extracellular bacteria were eliminated via gentamycin (indicate concentration used) treatment for 10 min. 
Macrophages were washed and lysed with 0.01% Triton X-100 at 20 min or at 2 h post-infection. Intracellular 
bacterial loads (CFU/ml) were assessed via plating on LB agar. Survival data are presented as a percentage of CFU 
present at t = 2 h compared to CFU at 20 min. Data are representative of 3 independent infections and the error 
bars represent the range of error of the replicates in a single experiment.
Bladder colonisation in a Mouse UTI model. All bacterial strains were enriched for the expression of 
type I fimbriae using static growth as previously described25. The C57BL/6 mouse model of UTI was used to 
assess in vivo survival as previously described53. Briefly, female C57BL/6 mice (8–10 weeks) were transurethrally 
inoculated54 with ~5 × 108 CFU using a 1 ml tuberculin syringe attached to a sterile catheter. After 2 days, urine 
and homogenated bladder and kidney samples were processed for bacterial loads by viable CFU counts (per-
formed in triplicate). The wild type strain had the gfp gene inserted into the lac operon (Table S3, Supplementary 
Information), so wild type could be discriminated from mutant by their appearance on MacConkey agar. Data 
are displayed as Log10 of the fitness index, which is defined as: Fitness index = (ratio of mutant:wild type after 2 
days)/(initial mutant:wild type ratio). A minimum of 8 mice were included in each strain group. Equality of group 
medians was tested using the Wilcoxon matched pairs signed rank test.
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